Literature DB >> 10671883

Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan.

Y Arai1, S Egawa, K Tobisu, K Sagiyama, Y Sumiyoshi, K Hashine, M Kawakita, T Matsuda, K Matsumoto, H Fujimoto, T Okada, Y Kakehi, T Terachi, O Ogawa.   

Abstract

OBJECTIVES: To assess the time trends, morbidity and mortality of contemporary anatomical radical retropubic prostatectomy (RRP) in a multi-institutional study in Japan, where RRP has become more popular in the last decade. PATIENTS AND METHODS: Between January 1991 and August 1998, 638 patients underwent RRP at seven urological centres in Japan. Major complications (within 30 days of surgery) and the 30-day mortality were reviewed retrospectively. Of the patients, 12.9% were < 60 years old, 56.3% were 60-69 years old and 30.9% were >/= 70 years old (median age 67). Results The number of RRPs increased markedly, by more than sevenfold, from 1991-92 to 1996-97, mainly because there were more patients undergoing RRP in their sixth decade. The contribution of T1c disease increased in absolute and relative terms, from 13.9% in 1991-92 to 37.9% in 1997-98. Over time, the mean blood loss and the allogeneic transfusion rate decreased steadily. There was a trend toward more favourable outcomes for pathological variables (an increased percentage of organ-confined disease, decreased margin positivity and a decreased incidence of positive lymph node metastasis). The most common complications were wound-related (7.5%), or anastomotic leakage (4.1%). Major cardiopulmonary complications occurred in only two patients (0.31%, both pulmonary embolisms). One patient died from cerebral haemorrhage within 30 days of surgery, giving a mortality rate of 0.16%.
CONCLUSION: s This study indicates a trend towards selecting patients most likely to benefit from RRP. Although the procedure is technically demanding, it can have an acceptably low rate of early complications, little mortality and need for allogeneic transfusion. The assessment of morbidity suggests a lower incidence of catastrophic thrombo-embolic and cardiac complications in Japanese patients than in Western men. The present data may be useful in decision-analysis models evaluating the role of therapy for Asian men with early-stage prostate cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10671883     DOI: 10.1046/j.1464-410x.2000.00468.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

1.  Recent advances in nonsurgical management of localized prostate cancer.

Authors:  Yoichi Arai
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

2.  Retropubic versus robot-assisted laparoscopic prostatectomy for prostate cancer: a comparative study of postoperative complications.

Authors:  Jeman Ryu; Taekmin Kwon; Yoon Soo Kyung; Sungwoo Hong; Dalsan You; In Gab Jeong; Choung-Soo Kim
Journal:  Korean J Urol       Date:  2013-11-06

3.  External-beam radiotherapy for clinically localized prostate cancer in Osaka, Japan, 1995-2006: time trends, outcome, and risk stratification.

Authors:  Yasuo Yoshioka; Osamu Suzuki; Kana Kobayashi; Teruki Teshima; Yuji Yamada; Tadayuki Kotsuma; Masahiko Koizumi; Kazufumi Kagawa; Masashi Chatani; Shigetoshi Shimamoto; Eiichi Tanaka; Hideya Yamazaki; Takehiro Inoue
Journal:  Strahlenther Onkol       Date:  2009-08-28       Impact factor: 3.621

4.  Perioperative blood loss in open retropubic radical prostatectomy - Is it safe to get operated at an educational hospital?

Authors:  A Karl; A Buchner; H Becker; M Staehler; M Seitz; C Stief
Journal:  Eur J Med Res       Date:  2009-07-22       Impact factor: 2.175

5.  Analysis of late toxicity associated with external beam radiation therapy for prostate cancer with uniform setting of classical 4-field 70 Gy in 35 fractions: a survey study by the Osaka Urological Tumor Radiotherapy Study Group.

Authors:  Yasuo Yoshioka; Osamu Suzuki; Kazuo Nishimura; Hitoshi Inoue; Tsuneo Hara; Ken Yoshida; Atsushi Imai; Akira Tsujimura; Norio Nonomura; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2012-09-17       Impact factor: 2.724

Review 6.  Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.

Authors:  Freesia Horsted; Joe West; Matthew J Grainge
Journal:  PLoS Med       Date:  2012-07-31       Impact factor: 11.069

7.  Do androgen deprivation and the biologically equivalent dose matter in low-dose-rate brachytherapy for intermediate-risk prostate cancer?

Authors:  Ryuji Tabata; Takahiro Kimura; Hidetoshi Kuruma; Hiroshi Sasaki; Masahito Kido; Kenta Miki; Hiroyuki Takahashi; Manabu Aoki; Shin Egawa
Journal:  Cancer Med       Date:  2016-07-25       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.